EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mecp2 promotes the anti‐inflammatory effect of alpinetin via epigenetic modification crosstalk

Ke Hu, Ruoting Ma, Minjiang Huang, Xiangyu Cao, Yan Ding, Yuxian Li, Yuefu Chen, Lijun Xiao, Sha Ling, Youliang Huang, Huiming Yin, Bifeng Tan iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Ke Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Hunan University of Medicine, Huaihua, China. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Flavanones, Epigenesis, Genetic, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The project of clinical medical technology demonstration base for hypertension prevention and treatment in huaihua city, hunan province, Joint project of Hunan Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, inflammatory disorders have emerged as a significant concern for human health. Through ongoing research on anti‐inflammatory agents, alpinetin has shown promising anti‐inflammatory properties, including involvement in epigenetic modification pathways. As a crucial regulator of epigenetic modifications, Mecp2 may play a role in modulating the epigenetic effects of alpinetin, potentially impacting its anti‐inflammatory properties. To test this hypothesis, two key components, p65 (a member of NF‐KB family) and p300 (a type of co‐activator), were screened by the expression profiling microarray, which exhibited a strong correlation with the intensity of LPS stimulation in mouse macrophages. Meanwhile, alpinetin demonstrates the anti‐inflammatory properties through its ability to disrupt the synthesis of p65 and its interaction with promoters of inflammatory genes, yet it did not exhibit similar effects on p300. Additionally, Mecp2 can inhibit the binding of p300 by attaching to the methylated inflammatory gene promoter induced by alpinetin, leading to obstacles in promoter acetylation and subsequently impacting the binding of p65, ultimately enhancing the anti‐inflammatory capabilities of alpinetin. Similarly, in a sepsis mouse model, it was observed that homozygotes overexpressing Mecp2 showed a greater reduction in organ damage and improved survival rates compared to heterozygotes when administered by alpinetin. However, blocking the expression of DNA methyltransferase 3A (DNMT3A) resulted in the loss of Mecp2′s anti‐inflammatory assistance. In conclusion, Mecp2 may augment the anti‐inflammatory effects of alpinetin through epigenetic ‘crosstalk’, highlighting the potential efficacy of a combined therapeutic strategy involving Mecp2 and alpinetin for anti‐inflammatory intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methyl-CpG-Binding Protein 2FlavanonesEpigenesis, GeneticAnti-Inflammatory AgentsPromoter Regions, GeneticAnimalsMiceRAW 264.7 CellsDNA MethylationLipopolysaccharidesTranscription Factor RelASepsisMacrophagesInflammationDNA Methyltransferase 3AMaleE1A-Associated p300 ProteinDisease Models, AnimalMice, Inbred C57BLDNA (Cytosine-5-)-Methyltransferases

Stichwörter der Autor:innen

P300acetylationalpinetininflammationmethylationmethyl‐CpG‐binding protein 2

Substanzen

Methyl-CpG-Binding Protein 2FlavanonesalpinetinAnti-Inflammatory AgentsMecp2 protein, mouseLipopolysaccharidesTranscription Factor RelADNA Methyltransferase 3AE1A-Associated p300 ProteinDnmt3a protein, mouse

Autor:innen und Institutionen

  • Medical College, Hunan University of Medicine, Huaihua, China.
  • Department of General Medicine, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Cardiology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, China.
  • Department of Respiratory and Critical Care Medicine, First Affiliated Hospital, Hunan University of Medicine, Huaihua, China.

ORCID-Profile: Bifeng Tan

Förderung

  • National Natural Science Foundation of China
  • The project of clinical medical technology demonstration base for hypertension prevention and treatment in huaihua city, hunan province
  • Joint project of Hunan Provincial Natural Science Foundation

Zitieren

APA

Hu, K., Ma, R., Huang, M., Cao, X., Ding, Y., Li, Y., Chen, Y., Xiao, L., Ling, S., Huang, Y., Yin, H., & Tan, B. (2024). Mecp2 promotes the anti‐inflammatory effect of alpinetin via epigenetic modification crosstalk. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18510

Vancouver

Hu K, Ma R, Huang M, Cao X, Ding Y, Li Y, et al. Mecp2 promotes the anti‐inflammatory effect of alpinetin via epigenetic modification crosstalk. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18510

BibTeX
@article{Hu2024,
  author = {Hu, Ke and Ma, Ruoting and Huang, Minjiang and Cao, Xiangyu and Ding, Yan and Li, Yuxian and Chen, Yuefu and Xiao, Lijun and Ling, Sha and Huang, Youliang and Yin, Huiming and Tan, Bifeng},
  title = {Mecp2 promotes the anti‐inflammatory effect of alpinetin via epigenetic modification crosstalk},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18510}
}
Kostenlos starten →